168 related articles for article (PubMed ID: 29337266)
1. Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus.
Naline E; Grassin Delyle S; Salvator H; Brollo M; Faisy C; Victoni T; Abrial C; Devillier P
Pulm Pharmacol Ther; 2018 Apr; 49():46-53. PubMed ID: 29337266
[TBL] [Abstract][Full Text] [Related]
2. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
[TBL] [Abstract][Full Text] [Related]
3. The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide.
Gavaldà A; Ramos I; Carcasona C; Calama E; Otal R; Montero JL; Sentellas S; Aparici M; Vilella D; Alberti J; Beleta J; Miralpeix M
Pulm Pharmacol Ther; 2014 Aug; 28(2):114-21. PubMed ID: 24928173
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi.
Rogliani P; Calzetta L; Ora J; Lipsi R; Segreti A; Matera MG; Cazzola M
Eur J Pharmacol; 2015 Aug; 761():383-90. PubMed ID: 25952728
[TBL] [Abstract][Full Text] [Related]
5. The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.
Tashkin DP
Expert Opin Drug Saf; 2015; 14(11):1759-72. PubMed ID: 26401729
[TBL] [Abstract][Full Text] [Related]
6. Characterization of V0162, a new long-acting antagonist at human M3 muscarinic acetylcholine receptors.
Heusler P; Cussac D; Naline E; Tardif S; Clerc T; Devillier P
Pharmacol Res; 2015 Oct; 100():117-26. PubMed ID: 26241178
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
[TBL] [Abstract][Full Text] [Related]
8. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Harrison S; Gigli PM; Janni A; Geppetti P; Civelli M; Patacchini R
Br J Pharmacol; 2006 Jun; 148(3):291-8. PubMed ID: 16565730
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic antagonists in early stage clinical development for the treatment of asthma.
Albertson TE; Chenoweth JA; Adams JY; Sutter ME
Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.
Cazzola M; Calzetta L; Puxeddu E; Ora J; Facciolo F; Rogliani P; Matera MG
Respir Res; 2016 Jun; 17(1):70. PubMed ID: 27296533
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi.
Cazzola M; Calzetta L; Page CP; Rogliani P; Facciolo F; Gavaldà A; Matera MG
Eur J Pharmacol; 2014 Dec; 745():135-43. PubMed ID: 25446566
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.
Ismaila AS; Huisman EL; Punekar YS; Karabis A
Int J Chron Obstruct Pulmon Dis; 2015; 10():2495-517. PubMed ID: 26604738
[TBL] [Abstract][Full Text] [Related]
14. Emerging muscarinic receptor antagonists for the treatment of asthma.
Matera MG; Belardo C; Rinaldi M; Rinaldi B; Cazzola M
Expert Opin Emerg Drugs; 2020 Jun; 25(2):123-130. PubMed ID: 32312134
[TBL] [Abstract][Full Text] [Related]
15. Long-acting muscarinic antagonists.
Melani AS
Expert Rev Clin Pharmacol; 2015; 8(4):479-501. PubMed ID: 26109098
[TBL] [Abstract][Full Text] [Related]
16. Long-acting muscarinic receptor antagonists for the treatment of respiratory disease.
Cazzola M; Page C; Matera MG
Pulm Pharmacol Ther; 2013 Jun; 26(3):307-17. PubMed ID: 23274274
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models.
Pulido-Rios MT; McNamara A; Obedencio GP; Ji Y; Jaw-Tsai S; Martin WJ; Hegde SS
J Pharmacol Exp Ther; 2013 Aug; 346(2):241-50. PubMed ID: 23685545
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic Receptor Antagonists.
Matera MG; Cazzola M
Handb Exp Pharmacol; 2017; 237():41-62. PubMed ID: 27787709
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium.
Katsumata M; Fujisawa T; Kamiya Y; Tanaka Y; Kamiya C; Inoue Y; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Maekawa M; Setou M; Watanabe H; Ikegami K; Suda T
BMC Pulm Med; 2022 May; 22(1):186. PubMed ID: 35527239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
